Trial Profile
A randomized, open-label, single dose, 2-treatment, 2-period, 2-way crossover study to assess the pharmacokinetic characteristics of YH14659, a fixed dose combination compared with coadministration of separate constituents under fasted condictions in healthy male subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Aspirin/clopidogrel (Primary) ; Aspirin; Clopidogrel
- Indications Coronary disorders; Embolism and thrombosis
- Focus Pharmacokinetics
- Sponsors Yuhan
- 12 May 2012 New trial record